NCT02544477View on ClinicalTrials.gov

High-flow Nasal Cannula Oxygen Versus Conventional Oxygen Therapy After Pulmonary Lobectomy

NACompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

September 30, 2018

Conditions
Respiratory InsufficiencyLung Cancer
Interventions
DEVICE

High-flow Nasal Cannula Oxygen (HFNCO)

DEVICE

Conventional oxygen treatment

Trial Locations (1)

00168

Fondazione Policlinico Universitario Agostino Gemelli, Rome

All Listed Sponsors
lead

Catholic University of the Sacred Heart

OTHER

NCT02544477 - High-flow Nasal Cannula Oxygen Versus Conventional Oxygen Therapy After Pulmonary Lobectomy | Biotech Hunter | Biotech Hunter